BH4 domain of bcl-2 protein is required for its proangiogenic function under hypoxic condition.
about
Apoptosis as anticancer mechanism: function and dysfunction of its modulators and targeted therapeutic strategiesSustained proliferation in cancer: Mechanisms and novel therapeutic targetsCaspase-8 contributes to angiogenesis and chemotherapy resistance in glioblastoma.Role of Bcl-2 and its associated miRNAs in vasculogenic mimicry of hepatocellular carcinoma.Affinity purification-mass spectrometry analysis of bcl-2 interactome identified SLIRP as a novel interacting protein.BH4 domain of Bcl-2 as a novel target for cancer therapyNon-canonical roles of Bcl-2 and Bcl-xL proteins: relevance of BH4 domain.miR-211 and MITF modulation by Bcl-2 protein in melanoma cells.
P2860
Q26750639-5490A156-AE25-46E0-881D-0E0C9E490688Q28396388-51F09C6A-62EF-4161-9A90-EE3866024C67Q33779029-A6056779-65A9-4A30-8418-FF4A372BF285Q36511720-CBE750E2-374F-4C22-8F64-4E6343057495Q36847519-1826D207-0CBA-41B3-9582-34AA17B1C9E0Q36940766-B33A9E4E-2A7C-45CC-84C1-EC0E7273FAFCQ38756877-72504B5C-3AE7-4BEF-B102-2E84FACA6020Q53266571-FC4B0487-DDB7-4C3C-817E-C4F7BD69D94B
P2860
BH4 domain of bcl-2 protein is required for its proangiogenic function under hypoxic condition.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
BH4 domain of bcl-2 protein is ...... ction under hypoxic condition.
@en
BH4 domain of bcl-2 protein is ...... ction under hypoxic condition.
@nl
type
label
BH4 domain of bcl-2 protein is ...... ction under hypoxic condition.
@en
BH4 domain of bcl-2 protein is ...... ction under hypoxic condition.
@nl
prefLabel
BH4 domain of bcl-2 protein is ...... ction under hypoxic condition.
@en
BH4 domain of bcl-2 protein is ...... ction under hypoxic condition.
@nl
P2093
P50
P356
P1433
P1476
BH4 domain of bcl-2 protein is ...... nction under hypoxic condition
@en
P2093
Antonio Candiloro
Daniela Passeri
Marta Di Martile
Teresa De Luca
P304
P356
10.1093/CARCIN/BGT242
P407
P50
P577
2013-07-08T00:00:00Z